Latest Aisling Capital Management LP Stock Portfolio
$471Million | No. of Holdings #14
Aisling Capital Management LP Performance
2026 Q2+6.41%
YTD+4.39%
2025+148.29%
About Aisling Capital Management LP and 13F Hedge Fund Stock Holdings
On 2026-08-13, the fund reported it's updated stock portfolio. In the 13F Holdings report, Aisling Capital Management LP reported an equity portfolio of $471.6 Millions as of 30 Jun, 2026. <br><br> The top stock holdings of Aisling Capital Management LP are BBIO, GLUE, SNDX. The fund has invested 72.5% of it's portfolio in BRIDGEBIO PHARMA INC and 8% of portfolio in MONTE ROSA THERAPEUTICS INC. <br><br> They significantly reduced their stock positions in BRIDGEBIO PHARMA INC (BBIO). Aisling Capital Management LP opened new stock positions in VTV THERAPEUTICS INC (VTVT).
Aisling Capital Management LP Equity Portfolio Value
Last Reported on: 13 Aug, 2026
$471Million
as of Aug 13, 2026Aisling Capital Management LP Annual Return Estimates Vs S&P 500
Our best estimate is that Aisling Capital Management LP made a return of 6.41% in the last quarter. In trailing 12 months, it's portfolio return was 82.8%.
- Performance
- S&P 500
New Buys
| Ticker | $ Bought |
|---|---|
| vtv therapeutics inc | 1,882,500 |
New stocks bought by Aisling Capital Management LP
Additions
No additions were made to existing positions by Aisling Capital Management LP
Reductions
| Ticker | % Reduced |
|---|---|
| bridgebio pharma inc | -9.82 |
Aisling Capital Management LP reduced stake in above stock
Sold off
None of the stocks were completely sold off by Aisling Capital Management LP
Sector Distribution
Aisling Capital Management LP has about 94.2% of it's holdings in Healthcare sector.
- Healthcare
- Others
| Sector | % |
|---|---|
| Healthcare | 94.2 |
| Others | 5.8 |
Market Cap. Distribution
Aisling Capital Management LP has about 72.5% of it's portfolio invested in the large-cap and mega-cap stocks.
- LARGE-CAP
- SMALL-CAP
- UNALLOCATED
| Category | % |
|---|---|
| LARGE-CAP | 72.5 |
| SMALL-CAP | 19.7 |
| UNALLOCATED | 5.8 |
Stocks belong to which Index?
About 89.4% of the stocks held by Aisling Capital Management LP either belong to S&P 500 or RUSSELL 2000 index.
- RUSSELL 2000
- Others
| Index | % |
|---|---|
| RUSSELL 2000 | 89.4 |
| Others | 10.6 |
Aisling Capital Management LP Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Aisling Capital Management LP
Aisling Capital Management LP has 14 stocks in it's portfolio. About 99% of the portfolio is in top 10 stocks. SNDX proved to be the most loss making stock for the portfolio. CMPS was the most profitable stock for Aisling Capital Management LP last quarter.
$471.62MTotal Value
14.00Positions
13 Aug, 2026Last Reported
| Expand | Holdingsorted ascending | % Portfolio | Shares Held | $ Value | % Change |
|---|---|---|---|---|---|
 Aclaris Therapeutics Inc Aisling Capital Management LP's holding in Aclaris Therapeutics Inc over time | 0.49% | 434,455 | $2.30M 0.49% | 0%unchanged 0 percentunchanged | |
 Bridgebio Pharma Inc Aisling Capital Management LP's holding in Bridgebio Pharma Inc over time | 72.48% | 4,589,610 | $341.83M 72.48% | 9.82%decreased 9.82 percentreduced | |
 Biomea Fusion Inc Aisling Capital Management LP's holding in Biomea Fusion Inc over time | 0.64% | 2,048,760 | $3.01M 0.64% | 0%unchanged 0 percentunchanged | |
 CMPS Compass Pathways PlcCompass Pathways PlcCMPS | 4.3% | 1,432,340 | $20.27M 4.3% | 0%unchanged 0 percentunchanged | |
 Monte Rosa Therapeutics Inc Aisling Capital Management LP's holding in Monte Rosa Therapeutics Inc over time | 7.98% | 1,555,660 | $37.65M 7.98% | 0%unchanged 0 percentunchanged | |
 Marker Therapeutics Inc Aisling Capital Management LP's holding in Marker Therapeutics Inc over time | 0.1% | 325,370 | $478.3K 0.1% | 0%unchanged 0 percentunchanged | |
 Syndax Pharmaceuticals Inc Aisling Capital Management LP's holding in Syndax Pharmaceuticals Inc over time | 6.1% | 1,316,810 | $28.79M 6.1% | 0%unchanged 0 percentunchanged | |
 Scholar Rock Hldg Corp Aisling Capital Management LP's holding in Scholar Rock Hldg Corp over time | 0.9% | 77,031 | $4.24M 0.9% | 0%unchanged 0 percentunchanged | |
 Urogen Pharma Ltd Aisling Capital Management LP's holding in Urogen Pharma Ltd over time | 0.84% | 108,000 | $3.97M 0.84% | 0%unchanged 0 percentunchanged | |
 Vtv Therapeutics Inc Aisling Capital Management LP's holding in Vtv Therapeutics Inc over time | 0.4% | 50,000 | $1.88M 0.4% | Newnew position | |
Com Bicara Therapeutics IncBicara Therapeutics Inc | 3.58% | 568,919 | $16.89M 3.58% | 0%unchanged 0 percentunchanged | |
Com New Bridgebio Oncology TherapeutBridgebio Oncology Therapeut | 1.65% | 1,018,020 | $7.76M 1.65% | 0%unchanged 0 percentunchanged | |
Com Eupraxia Pharmaceuticals IncEupraxia Pharmaceuticals Inc | 0.46% | 325,000 | $2.15M 0.46% | 0%unchanged 0 percentunchanged | |
Com Cl A Onkure Therapeutics IncOnkure Therapeutics Inc | 0.09% | 88,607 | $404.0K 0.09% | 0%unchanged 0 percentunchanged | |